SynthesisMolecular nutrition & food research2026
Human Milk Bioactive Compounds and Psychomotor Outcomes in Infants and Children: A Systematic Review.
Synthesis in Molecular nutrition & food research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Human milk (HM) provides nutrients and bioactive compounds (BCs) essential for healthy child development. This systematic review aimed to evaluate the short- and long-term effects of individual groups of BCs on psychomotor outcomes, including motor, cognitive, language, and executive functions. A comprehensive literature search was conducted in MEDLINE (PubMed), Scopus, Web of Science, and Embase in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Eligibility was defined using the PECOTS framework, focusing on healthy, term, breastfed children with follow-up up to 18 years. Study quality was assessed with the Joanna Briggs Institute (JBI) tool and Cochrane Risk of Bias (RoB 2) tools. Eighteen studies met the inclusion criteria. The most consistent evidence was for polyunsaturated fatty acids (PUFAs), particularly n-3 PUFAs, which were generally associated with favorable psychomotor outcomes throughout infancy and later childhood. In contrast, higher levels of n-6 PUFAs showed less consistent or potentially unfavorable associations. Among HM oligosaccharides, fucosylated HMOs were consistently associated with improved cognitive and language-related outcomes, whereas evidence for other HMO groups was limited and heterogeneous. Findings related to proteins, phospholipids, sphingolipids, and carotenoids were inconsistent. HM BCs, particularly n-3 PUFAs and fucosylated HMOs, may support psychomotor development in infancy, preschool age, and school age. However, the overall evidence remains heterogeneous. Further research using standardized methodologies is required to elucidate long-term effects and underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.